4//SEC Filing
Haasner Dirk 4
Accession 0001209191-20-054645
CIK 0001636651other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 4:41 PM ET
Size
5.5 KB
Accession
0001209191-20-054645
Insider Transaction Report
Form 4
Haasner Dirk
SVP, Global Regulatory Affairs
Transactions
- Award
Stock option (Right to Buy)
2020-10-11+20,000→ 20,000 totalExercise: $5.65Exp: 2030-10-10→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]50% of the shares subject to the Stock Option will vest and become exercisable on October 11, 2021 and the remaining shares will vest in 12 equal installments thereafter, subject to the Reporting Person's continued service through each such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001704660
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 4:41 PM ET
- Size
- 5.5 KB